Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1–Dependent Pathways
- 1 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (4) , 737-743
- https://doi.org/10.1161/01.atv.0000201087.23877.e1
Abstract
Objective— The mechanisms through which transforming growth factor (TGF)-β1 promotes intimal growth, and the pathways through which TGF-β1 expression is regulated in the artery wall, are incompletely understood. We used a mouse model to investigate mechanisms of TGF-β1–induced intimal growth. Methods and Results— Adenovirus-mediated overexpression of TGF-β1 in uninjured carotid arteries of wild-type mice induced formation of a cellular and matrix-rich intima. Intimal growth appeared primarily due to cell migration and matrix accumulation, with only a negligible contribution from cell proliferation. Overexpression of TGF-β1 also stimulated expression of plasminogen activator inhibitor type 1 (plasminogen activator inhibitor [PAI]-1) in the artery wall. To test the hypothesis that PAI-1 is a critical downstream mediator of TGF-β1–induced intimal growth, we transduced carotid arteries of PAI-1–deficient (Serpine1−/−) mice with the TGF-β1–expressing vector. Overexpression of TGF-β1 in Serpine1−/− arteries did not increase intimal growth, matrix accumulation, cell migration, or proliferation. Moreover, TGF-β1–transduced arteries of Serpine1−/− mice secreted 6- to 10-fold more TGF-β1 than did arteries of wild-type mice that were infused with the same concentration of the TGF-β1–expressing vector. Conclusions— PAI-1 is both a critical mediator of TGF-β1–induced intimal growth and a key negative regulator of TGF-β1 expression in the artery wall. We investigated mechanisms of TGF-β1–induced intimal growth. TGF-β1 induced neointimal formation through cell migration and matrix accumulation. Overexpression of TGF-β1 in arteries of PAI-1–deficient mice revealed that PAI-1 is both a critical mediator of TGF-β1–induced intimal growth and a key negative regulator of TGF-β1 expression in the artery wall.Keywords
This publication has 24 references indexed in Scilit:
- Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathyKidney International, 2005
- Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrinsThe Journal of cell biology, 2003
- Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and AngiogenesisJournal of Biological Chemistry, 2001
- TGF-β in the Cardiovascular SystemTrends in Cardiovascular Medicine, 2000
- Overexpression of transforming growth factor β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasiaProceedings of the National Academy of Sciences, 1998
- Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) miceNature, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Journal of Clinical Investigation, 1994
- Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.Journal of Clinical Investigation, 1992
- Production of transforming growth factor beta 1 during repair of arterial injury.Journal of Clinical Investigation, 1991
- The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.The Journal of cell biology, 1987